Cortexyme

$49.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.81 (+1.67%) Today
$0.00 (0.00%) As of 11:14 AM UTC after-hours

Why Robinhood?

You can buy or sell Cortexyme and other stocks, options, and ETFs commission-free!

About CRTX

Cortexyme, Inc. Common Stock, also called Cortexyme, is a biopharmaceutical company, which develops therapeutics based on data supporting a new theory of the cause of Alzheimer's and other neurodegenerative disorders. Its product, COR388, is in clinical trial. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA. The listed name for CRTX is Cortexyme, Inc. Common Stock.

CEO
Casey Crawford Lynch
Employees
23
Headquarters
South San Francisco, California
Founded
2012
Market Cap
1.46B
Price-Earnings Ratio
Dividend Yield
Average Volume
135.55K
High Today
$49.33
Low Today
$47.37
Open Price
$48.68
Volume
91.93K
52 Week High
$73.84
52 Week Low
$25.59

Collections

CRTX Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 16, After Hours

You May Also Like